Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20160920029889N4Phase 2Completed
Phase 2, open-label trial of colchicine and triamcinolone in aphthosis (RAS) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Lesion size, Pain and 1 more. Started Jan 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20160920029889N4.